# Impact of Low-dose Tamoxifen on BPU

> **NCT02979301** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 22 (actual)

## Conditions studied

- High Background Uptake on MBI

## Interventions

- **DRUG:** Tamoxifen

## Key facts

- **NCT ID:** NCT02979301
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2018-02-25
- **Final completion:** 2018-11-01
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2019-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02979301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02979301, "Impact of Low-dose Tamoxifen on BPU". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02979301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*